ApprovalTrail

Ingredient

Gentamicin

Products in Health Canada’s databases that list Gentamicin as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Also listed as “Gentamicin (Gentamicin Sulfate)” (65). How names are joined

Drug products
65
14 authorized now
Natural health products
0
0 active licences
Notices of Compliance
2
Products in all
65

Drug products

Authorized products first.

NameDINStatus
EASOTIC (1.5 MG)Virbac Ah, Inc. · Status since Feb 202102424576Marketed
GENTAMICIN INJECTION USP (40 MG)Sandoz Canada Inc. · Status since Aug 200502242652Marketed
GENTAMICIN INJECTION USP (10 MG)Sandoz Canada Inc. · Status since Aug 200502268531Marketed
GENTAMICIN INJECTION USP (40 MG)Hikma Canada Limited · Status since Jan 202402457008Marketed
GENTAMICIN INJECTION USP (10 MG)Hikma Canada Limited · Status since Jan 202402470462Marketed
GENTAMICIN(E) (1 MG)Baxter Corporation · Status since Dec 199502082136Marketed
GENTAMICIN(E) (1.6 MG)Baxter Corporation · Status since Dec 199502082152Marketed
GENTOCIN (100 MG)Intervet Canada Corp · Status since Jan 201300592293Marketed
MOMETAMAX (3 MG)Intervet Canada Corp · Status since May 201002344688Marketed
OTOMAX (3 MG)Intervet Canada Corp · Status since Feb 201100817112Marketed
TOPAGEN (0.57 MG)Intervet Canada Corp · Status since Apr 201400602841Marketed
GENTAMICIN (0.3 %)Steri-Med Pharma Inc. · Status since Feb 202502023776Approved
VALISONE-G (0.1 %)Bausch Health, Canada Inc. · Status since Jul 202200177016Dormant
VALISONE-G (0.1 %)Bausch Health, Canada Inc. · Status since Jul 202200232351Dormant
ALCOMICIN OPH SOL 3MG/ML (3 MG)Alcon Canada Inc. · Status since Apr 200900436771Cancelled Post Market
BETAMYCIN OPHTHALMIC/OTIC SOLUTION (3 MG)Sterimax Inc. · Status since Mar 201702247446Cancelled Pre Market
CIDOMYCIN INJ 10MG/ML (10 MG)Hoechst Roussel Canada Inc. · Status since Jul 200001989707Cancelled Post Market
CIDOMYCIN INJ 40MG/ML (40 MG)Roussel Canada Inc. · Status since Aug 199700259179Cancelled Post Market
CIDOMYCIN INJ 40MG/ML (40 MG)Hoechst Roussel Canada Inc. · Status since Aug 199901989693Cancelled Post Market
CIDOMYCIN INJ PEDIATRIC 10MG (10 MG)Roussel Canada Inc. · Status since Aug 199700259160Cancelled Post Market
DIPROGEN CREAM (0.1 %)Merck Canada Inc · Status since Mar 201700417262Cancelled Post Market
DIPROGEN OINTMENT (0.1 %)Merck Canada Inc · Status since Mar 201700417254Cancelled Post Market
DOM-GENTAMICIN-BETAMETHASONE (3 MG)Dominion Pharmacal · Status since May 201802238818Cancelled Pre Market
GARAMYCIN CREAM 0.1% (.1 %)Schering-Plough Canada Inc. · Status since Aug 200700027928Cancelled Post Market
GARAMYCIN ONT 0.1% (1 MG)Schering-Plough Canada Inc. · Status since Aug 200700028371Cancelled Post Market
GARAMYCIN OPHTHALMIC DROPS 0.3% (3 MG)Merck Canada Inc · Status since Sep 201400512192Cancelled Post Market
GARAMYCIN OPHTHALMIC OINTMENT 0.3% (0.3 %)Merck Canada Inc · Status since Jul 201300028339Cancelled Post Market
GARAMYCIN OTIC DROPS 0.3% (3 MG)Merck Canada Inc · Status since Mar 201400512184Cancelled Post Market
GARASOL INJECTABLE SOLUTION (5 MG)Schering-Plough Canada Inc. · Status since Aug 201100419028Cancelled Post Market
GARASOL PIG PUMP (4.35 MG)Schering-Plough Canada Inc. · Status since Aug 200900587915Cancelled Post Market
GARASONE OPHTHALMIC AND OTIC SOLUTION (3 MG)Merck Canada Inc · Status since Apr 201400682217Cancelled Post Market
GARASONE OPHTHALMIC OINTMENT (3 MG)Merck Canada Inc · Status since Jul 201300586706Cancelled Post Market
GENTAMICIN (0.3 %)Pharma Stulln Inc. · Status since Nov 201902023822Cancelled Post Market
GENTAMICIN (.3 %)Ivax Pharmaceuticals Incorporated · Status since Oct 201502219581Cancelled Post Market
GENTAMICIN SULFATE IN 0.9% SODIUM CHLORIDE INJECTION (0.8 MG)Hospira Healthcare Corporation · Status since Nov 201801913530Cancelled Post Market
GENTAMICIN SULFATE IN NACL 0.9% INJ (1.2 MG)Hospira Healthcare Corporation · Status since Aug 201101913093Cancelled Post Market
GENTAMICIN SULFATE IN NACL 0.9% INJ (1 MG)Hospira Healthcare Corporation · Status since Aug 201101913565Cancelled Post Market
GENTAMICIN SULFATE IN NACL O.9% INJ (0.8 MG)Hospira Healthcare Corporation · Status since Aug 201401913549Cancelled Post Market
GENTAMICIN SULPHATE 0.3% - LIQ OPH (3 MG)Rivex Ophthalmics Inc. · Status since Jul 200302212927Cancelled Post Market
GENTAMICIN SULPHATE INJECTION USP-10MG/ML (10 MG)Novopharm Limited · Status since Aug 200502145731Cancelled Post Market
GENTAMICIN SULPHATE INJECTION USP-40MG/ML (40 MG)Novopharm Limited · Status since Aug 200502145758Cancelled Post Market
GENTAMICIN(E) 120MG LIQ IV 1.2MG/ML (1.2 MG)Baxter Corporation · Status since Jul 201602082144Cancelled Post Market
GENTASUL 100 INJECTION 100MG/ML (100 MG)Ayerst Veterinary Laboratories · Status since Aug 200600813974Cancelled Post Market
GENTASUL-50 INJ 50MG/ML (50 MG)Langford · Status since Aug 200600728349Cancelled Post Market
GENTOCIN (3 MG)Intervet Canada Corp · Status since Feb 201300241636Cancelled Post Market
GENTOCIN DURAFILM (3 MG)Intervet Canada Corp · Status since Apr 202300256536Cancelled Post Market
GENTOCIN INJECTABLE SOLUTION 50MG/ML (50 MG)Schering-Plough Canada Inc. · Status since Aug 200900288179Cancelled Post Market
GENTOCIN INTRAUTERINE SOLUTION 10MG/ML (10 MG)Schering-Plough Canada Inc. · Status since Aug 200900392332Cancelled Post Market
GENTOCIN OTIC SOLUTION (3 MG)Schering-Plough Canada Inc. · Status since Aug 200900256544Cancelled Post Market
GENTOCIN SPRAY 1.1MG/ML (1.1 MG)Schering-Plough Canada Inc. · Status since Aug 200900573787Cancelled Post Market
PMS-GENTAMICIN CREAM 1MG/GM (1 MG)Pharmascience Inc. · Status since Jan 201800872873Cancelled Post Market
PMS-GENTAMICIN OINTMENT 1MG/GM (1 MG)Pharmascience Inc. · Status since Jan 201800872881Cancelled Post Market
PMS-GENTAMICIN OPHTHALMIC OINTMENT 0.3% (0.3 %)Pharmascience Inc. · Status since Sep 201702237689Cancelled Pre Market
PMS-GENTAMICIN OTIC DROPS 0.3% (3 MG)Pharmascience Inc. · Status since Sep 201702230889Cancelled Post Market
PMS-GENTAMICIN SULFATE OPH DPS 0.3% (3 MG)Pharmascience Inc. · Status since Jan 201800776521Cancelled Post Market
PMS-GENTAMICIN-BETAMETHASONE (3 MG)Pharmascience Inc. · Status since Mar 201802238819Cancelled Pre Market
R.O.-GENTYCIN (3 MG)Richmond Pharmaceuticals Inc. · Status since Aug 199701933299Cancelled Post Market
RATIO-GENTAMICIN (.1 %)Ratiopharm Inc Division Of Teva Canada Limited · Status since Jul 201600805025Cancelled Post Market
RATIO-GENTAMICIN (0.1 %)Ratiopharm Inc Division Of Teva Canada Limited · Status since Jul 201600805386Cancelled Post Market
SANDOZ GENTAMICIN (3 MG)Sandoz Canada Inc. · Status since Aug 201702229440Cancelled Post Market
SANDOZ GENTAMICIN (3 MG)Sandoz Canada Inc. · Status since Aug 201902229441Cancelled Post Market
SANDOZ GENTAMICIN (3 MG)Sandoz Canada Inc. · Status since Aug 201702230888Cancelled Post Market
SANDOZ PENTASONE (3 MG)Sandoz Canada Inc. · Status since Aug 201702244999Cancelled Post Market
SEPTOPAL (4.5 MG)Biomet Orthopedics, Inc. · Status since Jul 201400646350Cancelled Post Market
TOPAGEN ONT (5.25 MG)Schering-Plough Canada Inc. · Status since Sep 199800489905Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.